Metropolitan Life Insurance CO Rhythm Pharmaceuticals, Inc. Transaction History

Metropolitan Life Insurance CO

$253 Million
Q2 2024

42 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$39.12 - $52.44 $6,102 - $8,180	-156 Reduced 5.26%	2,812 $121,000
Q3 2023 Nov 14, 2023	BUY	$15.81 - $27.8 $2,482 - $4,364	157 Added 5.59%	2,968 $68,000
Q2 2023 Aug 10, 2023	BUY	$16.32 - $21.15 $45,875 - $59,452	2,811 New	2,811 $46,000
Q2 2022 Aug 11, 2022	SELL	$3.12 - $12.25 $9,472 - $37,191	-3,036 Closed	0 $0
Q1 2022 Jun 20, 2023	BUY	$6.13 - $12.24 $18,610 - $37,160	3,036 New	3,036 $34,000
Q1 2022 Mar 30, 2023	SELL	$6.13 - $12.24 $27,572 - $55,055	-4,498 Reduced 59.7%	3,036 $34,000
Q1 2022 May 12, 2022	SELL	$6.13 - $12.24 $27,572 - $55,055	-4,498 Reduced 59.7%	3,036 $35,000
Q4 2021 Jun 21, 2023	BUY	$8.62 - $13.9 $64,943 - $104,722	7,534 New	7,534 $75,000
Q4 2021 Mar 30, 2023	SELL	$8.62 - $13.9 $10,852 - $17,500	-1,259 Reduced 14.32%	7,534 $75,000
Q4 2021 Feb 15, 2022	SELL	$8.62 - $13.9 $10,852 - $17,500	-1,259 Reduced 14.32%	7,534 $75,000
Q3 2021 Jun 21, 2023	BUY	$11.68 - $20.72 $102,702 - $182,190	8,793 New	8,793 $114,000
Q3 2021 Mar 30, 2023	SELL	$11.68 - $20.72 $42,713 - $75,773	-3,657 Reduced 29.37%	8,793 $114,000
Q3 2021 Nov 15, 2021	SELL	$11.68 - $20.72 $42,713 - $75,773	-3,657 Reduced 29.37%	8,793 $115,000
Q2 2021 Jun 21, 2023	BUY	$18.52 - $22.55 $230,574 - $280,747	12,450 New	12,450 $243,000
Q2 2021 Mar 30, 2023	BUY	$18.52 - $22.55 $52,504 - $63,929	2,835 Added 29.49%	12,450 $243,000
Q2 2021 Aug 16, 2021	BUY	$18.52 - $22.55 $230,388 - $280,522	12,440 Added 124400.0%	12,450 $244,000
Q1 2021 Jun 26, 2023	BUY	$20.25 - $39.49 $194,703 - $379,696	9,615 New	9,615 $205 Million
Q1 2021 Mar 30, 2023	SELL	$20.25 - $39.49 $9,861 - $19,231	-487 Reduced 4.82%	9,615 $204,000
Q1 2021 May 14, 2021	SELL	$20.25 - $39.49 $204,363 - $398,533	-10,092 Reduced 99.9%	10 $205,000
Q4 2020 Jun 22, 2023	BUY	$21.17 - $32.61 $213,859 - $329,426	10,102 New	10,102 $300,000
Q3 2020 Jun 26, 2023	BUY	$18.13 - $30.61 $183,149 - $309,222	10,102 New	10,102 $218,000
Q2 2020 Jun 26, 2023	BUY	$14.41 - $25.35 $145,569 - $256,085	10,102 New	10,102 $225,000
Q1 2020 Jul 12, 2023	BUY	$13.16 - $22.9 $132,942 - $231,335	10,102 New	10,102 $153,000
Q1 2020 Mar 30, 2023	BUY	$13.16 - $22.9 $8,751 - $15,228	665 Added 7.05%	10,102 $153,000
Q1 2020 May 15, 2020	BUY	$13.16 - $22.9 $8,751 - $15,228	665 Added 7.05%	10,102 $154,000
Q4 2019 Jul 12, 2023	BUY	$19.53 - $25.5 $184,304 - $240,643	9,437 New	9,437 $216,000
Q4 2019 Mar 30, 2023	BUY	$19.53 - $25.5 $25,252 - $32,971	1,293 Added 15.88%	9,437 $216,000
Q4 2019 Feb 14, 2020	BUY	$19.53 - $25.5 $25,252 - $32,971	1,293 Added 15.88%	9,437 $217,000
Q3 2019 Jul 12, 2023	BUY	$18.62 - $24.51 $151,641 - $199,609	8,144 New	8,144 $175,000
Q3 2019 Mar 30, 2023	BUY	$18.62 - $24.51 $67,814 - $89,265	3,642 Added 80.9%	8,144 $175,000
Q3 2019 Nov 14, 2019	BUY	$18.62 - $24.51 $67,814 - $89,265	3,642 Added 80.9%	8,144 $176,000
Q2 2019 Jul 12, 2023	BUY	$21.11 - $28.48 $109,582 - $147,839	5,191 New	5,191 $114,000
Q1 2019 Jul 13, 2023	BUY	$24.76 - $31.66 $111,469 - $142,533	4,502 New	4,502 $123,000
Q1 2019 Mar 30, 2023	BUY	$24.76 - $31.66 $111,469 - $142,533	4,502 New	4,502 $123,000
Q1 2019 May 16, 2019	BUY	$24.76 - $31.66 $10,894 - $13,930	440 Added 10.83%	4,502 $123,000
Q1 2019 May 15, 2019	SELL	$24.76 - $31.66 $23,720 - $30,330	-958 Reduced 19.08%	4,062 $341,000
Q4 2018 Jul 13, 2023	BUY	$24.11 - $31.34 $121,032 - $157,326	5,020 New	5,020 $134,000
Q4 2018 Feb 14, 2019	BUY	$24.11 - $31.34 $97,934 - $127,303	4,062 Added 424.01%	5,020 $135,000
Q3 2018 Jul 13, 2023	BUY	$26.99 - $35.85 $118,027 - $156,772	4,373 New	4,373 $128 Million
Q3 2018 Nov 14, 2018	BUY	$26.99 - $35.85 $25,856 - $34,344	958 New	958 $28,000
Q1 2018 May 15, 2018	SELL	$19.9 - $32.25 $134,464 - $217,913	-6,757 Closed	0 $0
Q4 2017 Feb 15, 2018	BUY	$22.0 - $30.51 $148,654 - $206,156	6,757	6,757 $196,000

Others Institutions Holding RYTM

# of Institutions

178

Shares Held

69.1M

Call Options Held

467K

Put Options Held

224K

Primecap Management CO Pasadena, CA

7.31M
Shares

$375 Million
0.22% of portfolio
Black Rock Inc. New York, NY

6.74M
Shares

$346 Million
0.01% of portfolio
Baker Bros. Advisors LP New York, NY

6.4M
Shares

$329 Million
3.49% of portfolio
Ra Capital Management, L.P. Boston, MA

6.08M
Shares

$312 Million
3.77% of portfolio
Goldman Sachs Group Inc New York, NY

5.29M
Shares

$272 Million
0.04% of portfolio

View Full List

About RHYTHM PHARMACEUTICALS, INC.

Ticker RYTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,720,000
Market Cap $2.86B
Description
Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convert...

More about RYTM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.

Account